Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma.
Sci Transl Med. 2018 Nov 14;10(467):eaat5933. doi: 10.1126/scitranslmed.aat5933.
Sci Transl Med. 2018.
PMID: 30429355
Free PMC article.